is being presented by Dr. Anita S. Kablinger, Virginia Tech Carilion School of Medicine and airs on February 15th, 2011. For more details or to register, please visit our site at www.fxconferences.com
Clinical researchers face a steep learning curve. The importance of research, as well as the practice of participation in research, remains a relatively minor component of medical school and graduate medical education. Clinical investigators often have limited knowledge of the FDA rules and regulations in drug development other aspects of clinical research.
This presentation reviews the FDA guidance concerning what the clinical investigator – as well as those seeking qualified investigators – needs to know and demonstrate to provide academic rigor, maintain the highest safety standards of participants and promote the development of novel compounds and devices.
Over 50,000 attendees across hundreds of companies have taken advantage of our easy-to-use audio conferences to stay abreast of a fast-changing business environment. We specialize in Life Science conferences, along with topics relevant for HR, Marketing, Legal, and Finance professionals. Come check out our library of past audio conferences and see what's upcoming at FXConferences
Showing posts with label Virginia Tech Carilion School of Medicine. Show all posts
Showing posts with label Virginia Tech Carilion School of Medicine. Show all posts
Monday, January 17, 2011
Friday, October 15, 2010
Academic Medical Centers and Clinical Research Productivity: How to Choose The Best Sites
is being presented by Anita S. Kablinger, Physician, Carilion Clinic
, Virginia Tech Carilion School of Medicine and airs on Tuesday, November 23rd, 2010. For more details or to register, please visit our site at www.fxconferences.com
Fulfilling enrollment numbers for clinical trials and providing the required data is of utmost concern to industry. Subject selection must be accurate and swift to meet deadlines. Recruitment remains one of the most difficult aspects of clinical research and choosing sites that will produce good clinical data of truly ill patients is always hard. Literature suggests that, although private research sites often achieve enrollment numbers in a timely fashion, academic center subject selection frequently represents sicker patients with a subsequent lower placebo response. How then does industry and its partners determine the appropriate sites for a multi-center trial to achieve success?
This presentation reviews the important aspects of site selection with respect to academic medical centers, with the goal of maximizing efficiency and productivity of all those involved and increasing the probability of study success.
, Virginia Tech Carilion School of Medicine and airs on Tuesday, November 23rd, 2010. For more details or to register, please visit our site at www.fxconferences.com
Fulfilling enrollment numbers for clinical trials and providing the required data is of utmost concern to industry. Subject selection must be accurate and swift to meet deadlines. Recruitment remains one of the most difficult aspects of clinical research and choosing sites that will produce good clinical data of truly ill patients is always hard. Literature suggests that, although private research sites often achieve enrollment numbers in a timely fashion, academic center subject selection frequently represents sicker patients with a subsequent lower placebo response. How then does industry and its partners determine the appropriate sites for a multi-center trial to achieve success?
This presentation reviews the important aspects of site selection with respect to academic medical centers, with the goal of maximizing efficiency and productivity of all those involved and increasing the probability of study success.
Subscribe to:
Posts (Atom)